Millipore Sigma Vibrant Logo

420336 KB-R7943 - CAS 182004-65-5 - Calbiochem

KB-R7943 - CAS 182004-65-5 - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: 2-(2-(4-(4-Nitrobenzyloxy)phenyl)ethyl)isothiourea, methane sulfonate, NMDA Antagonist III

Primary Target: Na+/Ca2+ exchangers
View Products on Sigmaaldrich.com
420336
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
182004-65-5C₁₆H₁₇N₃O₃S • MeSO₃H

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
420336-5MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 5 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewA cell-permeable isothiourea derivative that inhibits the influx/reverse mode of Na+/Ca2+ exchangers (NCX; IC50 = 4.3 µM, 4.7 µM, and 1.4 µM for NCX1,NCX2, and NCX3, respectively) and directly modulates Na+/Mg2+ exchange in a Ca2+-dependent manner. Reported to offer neuronal and cardioprotection. Also inhibits nicotinic acetylcholine receptors and NMDA receptor channels (IC50 < 10 µM).
      Catalogue Number420336
      Brand Family Calbiochem®
      Synonyms2-(2-(4-(4-Nitrobenzyloxy)phenyl)ethyl)isothiourea, methane sulfonate, NMDA Antagonist III
      References
      ReferencesHobai, I.A., and O'Rourke, B. 2004. Expert Opin. Investig. Drugs 13, 653.
      Uetani, T., et al. 2003. J. Biol. Chem. 278, 47491.
      Iwamoto, T., et al. 2001. Mol. Pharmacol. 59, 524.
      Pintado, A.J., et al. 2000. Br. J. Pharmacol. 130, 1893.
      Sobolevsky, A.I., and Khodorov, B.I. 1999. Neuropharmacology 38, 1235.
      Iwamoto, T., et al. 1996. J. Biol. Chem. 271, 22391.
      Watano, T., et al. 1996. Br. J. Pharmacol. 119, 555.
      Product Information
      CAS number182004-65-5
      ATP CompetitiveN
      FormWhite crystalline solid
      Hill FormulaC₁₆H₁₇N₃O₃S • MeSO₃H
      Chemical formulaC₁₆H₁₇N₃O₃S • MeSO₃H
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetNa+/Ca2+ exchangers
      Primary Target IC<sub>50</sub>4.3 µM, 4.7 µM, and 1.4 µM for NCX1,NCX2, and NCX3, respectively
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      420336-5MG 07790788050160

      Documentation

      KB-R7943 - CAS 182004-65-5 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      KB-R7943 - CAS 182004-65-5 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      420336

      Riferimenti bibliografici

      Panoramica delle referenze
      Hobai, I.A., and O'Rourke, B. 2004. Expert Opin. Investig. Drugs 13, 653.
      Uetani, T., et al. 2003. J. Biol. Chem. 278, 47491.
      Iwamoto, T., et al. 2001. Mol. Pharmacol. 59, 524.
      Pintado, A.J., et al. 2000. Br. J. Pharmacol. 130, 1893.
      Sobolevsky, A.I., and Khodorov, B.I. 1999. Neuropharmacology 38, 1235.
      Iwamoto, T., et al. 1996. J. Biol. Chem. 271, 22391.
      Watano, T., et al. 1996. Br. J. Pharmacol. 119, 555.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-July-2008 RFH
      Synonyms2-(2-(4-(4-Nitrobenzyloxy)phenyl)ethyl)isothiourea, methane sulfonate, NMDA Antagonist III
      DescriptionA cell-permeable inhibitor of the influx/reverse mode of the Na+/Ca2+ exchanger (NCX) (IC50 = 4.3 µM for NCX1, 4.7 µM for NCX2, and 1.4 µM for NCX3). Directly modulates Na+/Mg2+ exchange in a Ca2+-dependent manner. Reported ot offer neuronal and cardio-protection against ischemic injury. Also inhibits nicotinic acetylcholine receptors and NMDA receptor channels (IC50 <10 µM).
      FormWhite crystalline solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number182004-65-5
      Chemical formulaC₁₆H₁₇N₃O₃S • MeSO₃H
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (40 mg/ml) or H₂O (4 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Irritant
      ReferencesHobai, I.A., and O'Rourke, B. 2004. Expert Opin. Investig. Drugs 13, 653.
      Uetani, T., et al. 2003. J. Biol. Chem. 278, 47491.
      Iwamoto, T., et al. 2001. Mol. Pharmacol. 59, 524.
      Pintado, A.J., et al. 2000. Br. J. Pharmacol. 130, 1893.
      Sobolevsky, A.I., and Khodorov, B.I. 1999. Neuropharmacology 38, 1235.
      Iwamoto, T., et al. 1996. J. Biol. Chem. 271, 22391.
      Watano, T., et al. 1996. Br. J. Pharmacol. 119, 555.